| Primary information |
|---|
| ID | 11404 |
| Uniprot ID | P12707 |
| Description | Insulin-2 precursor [Cleaved into- - Insulin-2 B chain; Insulin-2 A chain]. |
| Organism | Xenopus laevis |
| Txonomy | Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;Amphibia; Batrachia; Anura; Mesobatrachia; Pipoidea; Pipidae;Xenopodinae; Xenopus; Xenopus. |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the insulin family. |
| Tissue Specificity | NA |
| Post Translational Modification | NA |
| Function | Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides; amino acids and fatty acids. It accelerates glycolysis; the pentose phosphate cycle; and glycogen synthesis in liver |
| Length | 106 |
| Molecular Weight | 12207 |
| Name | Insulin-2 B chain |
| Sequence | LANQHLCGSHLVEALYLVCGDRGFFYYPKI |
| Sequence map | 30 (24-53) |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | Q9PVZ4 |
| Domain | NA |
| Pharmaceutical Use | NA
|